南美洲和中美洲膀胱过度活动症治疗市场预测至 2028 年 – COVID-19 影响和区域分析 – 按药物治疗（抗胆碱能药物、米拉贝隆、肉毒杆菌、神经刺激和膀胱灌注）和疾病类型（特发性膀胱过度活动症和神经源性膀胱） � �
No. of Pages: 124 | Report Code: BMIRE00027968 | Category: Life Sciences
No. of Pages: 124 | Report Code: BMIRE00027968 | Category: Life Sciences
合并数量不断增加收购正在推动 South &中美洲膀胱过度活动症治疗市场增长
通过并购 (M&A)，公司可以通过进入新市场和获取新技术来获得竞争优势。膀胱过度活动症治疗市场正在进行的并购正在为各公司创造增长机会。 2021 年 7 月，Uro Medical 通过收购 Micron Medical 加强了其泌尿科产品组合，该公司提供无线供电、可注射、微技术神经刺激器，专注于治疗膀胱过度活动症。这些神经刺激器可以很容易地融入患者体内。为日常生活提供便捷、安全、微创、经济的泌尿外科治疗选择。 2021 年 2 月，医疗技术公司 Axonics Modulation Technologies, Inc. 收购了 Contura Ltd. 及其专有产品 Bulkamid，该产品是一种针对女性压力性尿失禁 (SUI) 的尿道填充剂。 Axonics 生产和销售用于治疗泌尿和肠道功能障碍的新型植入式骶神经调节 (SNM) 装置。收购 Contura Ltd. 提供了在全球范围内扩展 SNM 业务并服务于渗透率极低的大型 SUI 市场的机会。该公司计划为泌尿妇科医生和泌尿科医生提供一整套临床差异化的失禁解决方案来治疗他们的患者。因此，越来越多的并购正在推动South & Co.的发展。中美洲膀胱过度活动症治疗市场增长
南美洲和南美洲中美洲膀胱过度活动症治疗市场概览
南部和南部地区中美洲膀胱过度活动症治疗市场分为巴西、阿根廷和南美其他地区。中美洲。巴西预计将占据该地区最大的市场份额，并且预计在预测期内复合年增长率最高。市场增长归因于老年人口的增长和慢性疾病患病率的上升。该地区肥胖、不健康的生活方式和其他风险的患病率很高，这些都导致了膀胱过度活动症候群。因此，整个地区对膀胱过度活动症治疗的认识有所提高，这正在影响该地区的市场增长。
南和北中美洲膀胱过度活动症治疗市场细分
南部和中部地区中美洲膀胱过度活动症治疗市场根据药物治疗、疾病类型和国家进行细分。
根据药物治疗，南美洲和南美洲;中美洲膀胱过度活动症治疗市场分为抗胆碱能药物、米拉贝隆、肉毒杆菌、神经刺激和膀胱灌注。米拉贝隆细分市场在 2022 年占据了最大的市场份额。中美洲膀胱过度活动症治疗市场分为特发性膀胱过度活动症和神经源性膀胱。 2022 年，特发性膀胱过度活动症细分市场占据了更大的市场份额。中美洲膀胱过度活动症治疗市场分为巴西、阿根廷和南美其他地区。中美洲。巴西将在 2022 年占据市场主导地位。
AbbVie Inc;安斯泰来制药公司；远藤制药公司；久光制药有限公司；美敦力公司；辉瑞公司；和 Teva Pharmaceutical Industries Ltd 是在南部和南部地区运营的领先公司。中美洲膀胱过度活动症治疗市场。
Strategic insights for South & Central America Overactive Bladder Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 472.49 Million |
| Market Size by 2028 | US$ 543.53 Million |
| Global CAGR (2022 - 2028) | 2.4% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 药物治疗
|
| Regions and Countries Covered | 南美洲和中美洲
|
| Market leaders and key company profiles |
The regional scope of South & Central America Overactive Bladder Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The South & Central America Overactive Bladder Treatment Market is valued at US$ 472.49 Million in 2022, it is projected to reach US$ 543.53 Million by 2028.
As per our report South & Central America Overactive Bladder Treatment Market, the market size is valued at US$ 472.49 Million in 2022, projecting it to reach US$ 543.53 Million by 2028. This translates to a CAGR of approximately 2.4% during the forecast period.
The South & Central America Overactive Bladder Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Overactive Bladder Treatment Market report:
The South & Central America Overactive Bladder Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Overactive Bladder Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Overactive Bladder Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South & Central America Overactive Bladder Treatment Market
